ITP
Iron Triangle Partners’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,217,730
| Closed | -$34.1M | – | 36 |
|
|
2025
Q1 | $34.1M | Buy |
2,217,730
+17,694
| +0.8% | +$272K | 5.37% | 4 |
|
|
2024
Q4 | $48.5M | Buy |
2,200,036
+256,246
| +13% | +$5.65M | 5.34% | 5 |
|
|
2024
Q3 | $35M | Sell |
1,943,790
-1,356,395
| -41% | -$24.4M | 4.85% | 8 |
|
|
2024
Q2 | $53.6M | Buy |
3,300,185
+530,321
| +19% | +$8.62M | 5.45% | 7 |
|
|
2024
Q1 | $39.1M | Buy |
2,769,864
+1,469,864
| +113% | +$20.7M | 4% | 12 |
|
|
2023
Q4 | $13.6M | Buy |
+1,300,000
| New | +$13.6M | 1.76% | 25 |
|
|
2020
Q2 | – | Sell |
-1,000,000
| Closed | -$8.98M | – | 32 |
|
|
2020
Q1 | $8.98M | Buy |
+1,000,000
| New | +$8.98M | 3.47% | 13 |
|